Muscle & Nerve · 2022 · 12 citations · 13 references
MedicineNeurologyNeuroscienceElectrophysiologyNeuropathologyNeurophysiologyElectrodiagnostic InterpretationMotor NeuropathyNerve Conduction StudiesNeurological AssessmentPeripheral Nerve DisordersPeripheral NeuropathiesAxonal PolyneuropathyCompound Muscle Action Potential AnalysisElectrodiagnostic CriteriaMedian Nerve ConductionNerve Conduction Study InterpretationSensory Nerve Action Potential AnalysisSensory Nerve ConductionVasculitic Neuropathology
INTRODUCTION/AIMS: In vasculitic neuropathy (VN), a 50% side-to-side difference in the amplitude of compound muscle action potentials and sensory nerve action potentials is considered meaningful, but unequivocal evidence is lacking. The aim of this study is to characterize electrodiagnostic features that best distinguish VN from other axonal polyneuropathies. METHODS: We conducted a case-control study between January 2000 and April 2021. We reviewed the records of patients with VN who had bilateral nerve conduction studies (NCS) and evaluated different electrodiagnostic models to help distinguish VN from non-inflammatory axonal polyneuropathies. RESULTS: We identified 82 cases, and 174 controls with non-inflammatory axonal neuropathies. The amplitude percent difference Z-score model showed the best discriminatory capability between cases and controls (area under the curve [AUC] 0.87; 95% confidence interval [CI] 0.82, 0.93), and the number of nerves tested did not significantly influence the model. Individually, the ulnar motor nerve (AUC 0.86; 95% CI 0.77, 0.94) and median motor nerve (AUC 0.85; 95% CI 0.77, 0.94) showed the best discriminatory capability. A 50% amplitude difference between at least two bilateral nerves, either in the upper (AUC 0.85; 95% CI 0.77, 0.93) or lower (AUC 0.79; 95% CI 0.71, 0.87) extremity showed good discriminatory threshold for detecting VN. DISCUSSION: The best electrodiagnostic criteria for VN utilizes z-scores of percent differences in nerve amplitudes, but this approach may be difficult to implement at the bedside. Alternately, a 50% amplitude difference in at least two nerves is a reasonable approximation.
13
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
John H. Stone, Peter A. Merkel, Robert Spiera et al. · New England Journal of Medicine · 2010 · 2.7K citations · Full text
Michael P. Collins, P. James B. Dyck, Gary Gronseth et al. · Journal of the Peripheral Nervous System · 2010 · 281 citations
The peripheral neuropathy of necrotizing arteritis: A clinicopathological study
Gérard Saïd, C Lacroix-Ciaudo, Harustoshi Fujimura et al. · Annals of Neurology · 1988 · 271 citations
Kelly Gwathmey, Ted M. Burns, Michael P. Collins et al. · The Lancet Neurology · 2013 · 171 citations